New research reveals that the flexible ‘fuzzy coat’ surrounding α-synuclein fibrils plays a critical role in how Parkinson’s disease spreads between brain cells. Parkinson’s disease (PD) and Lewy body ...

In this first interview of a two-part series, Andreas Kolleger explores the convergence of knowledge graphs and large language models. As the head of GenAI innovation at Neo4j, Andreas brings a unique ...

A specialised group of immune cells in the gut has been found to prevent allergic reactions - a discovery that could lead to new treatments for allergies and autoimmune diseases.

Find out how LB Pharmaceuticals’ LB-102 is advancing schizophrenia treatment. This first-in-class antipsychotic demonstrates strong efficacy, safety and tolerability, potentially addressing both acute ...

21 April 2025 | By Andreas Kollegger (Head of GenAI innovation at Neo4), Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers) In this first interview of a two-part series, Andreas Kolleger ...

A specialised group of immune cells in the gut has been found to prevent allergic reactions – a discovery that could lead to new treatments for allergies and autoimmune diseases. Our immune system ...

Explore the latest findings on genetic networks and their role in DNA repair, opening new avenues for cancer therapies.

A preclinical study conducted by researchers at Weill Cornell Medicine have demonstrated a new gene-editing strategy to treat short bowel syndrome (SBS), a life-threatening condition in which patients ...

Discover how Immorta Bio's cellular therapies are addressing cancer and liver failure, with the potential to transform healthcare.

A preclinical study conducted by researchers at Weill Cornell Medicine have demonstrated a new gene-editing strategy to treat short bowel syndrome (SBS), a life-threatening condition in which patients ...